Roy Buchanan
Stock Analyst at JMP Securities
(0)
# 4818
Out of 5,240 analysts
53
Total ratings
30.95%
Success rate
-25.53%
Average return
Main Sectors:
Top Industries:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
Inovio Pharmaceutica... | Reiterates: Market Outperform | 18 18 | 1.86 | 867.74% | 2 | Jan 10, 2025 | |
Abivax | Reiterates: Market Outperform | 33 33 | 6.19 | 433.12% | 1 | Jan 10, 2025 | |
Enanta Pharma | Reiterates: Market Outperform | 22 21 | 4.86 | 332.1% | 11 | Nov 26, 2024 | |
HOOKIPA Pharma | Maintains: Market Outperform | 24 7 | 1.86 | 276.34% | 2 | Nov 21, 2024 | |
AN2 Therapeutics | Reiterates: Market Outperform | 5 5 | 1.23 | 306.5% | 5 | Nov 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | n/a | n/a | n/a | 5 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Market Outperform | 16 16 | 3.93 | 307.12% | 7 | Sep 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Outperform | 4 5 | 3.19 | 56.74% | 5 | Aug 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Outperform | 25 27 | 12.47 | 116.52% | 5 | Nov 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | n/a | n/a | n/a | 3 | Jul 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Market Outperform | 15 | 2.26 | 563.72% | 1 | Mar 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Outperform | 443 448 | 665.84 | -32.72% | 2 | Mar 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Perform | 14 16 | 11.22 | 42.6% | 1 | Mar 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | n/a | n/a | n/a | 2 | Feb 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Market Outperform | 420 | 3.09 | 13492.23% | 1 | Sep 14, 2021 |